Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research - Page 21

  1. Cat.No. Product Name Information/Activity
  2. BCC6790 (+)-UH 232 maleate 1217473-50-1 (+)-UH 232 maleate chemical structure
  3. BCC2072 Ziprasidone hydrochloride monohydrate Ziprasidone hydrochloride monohydrate (CP 88059 hydrochloride monohydrate) is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects of antipsychotic activity. Ziprasidone hydrochloride monohydrate chemical structure
  4. BCC7838 Zotepine 26615-21-4 Zotepine chemical structure
  5. BCC6353 PAOPA 114200-31-6 PAOPA chemical structure
  6. BCC6756 7-Hydroxy-DPAT hydrobromide 76135-30-3 7-Hydroxy-DPAT hydrobromide chemical structure
  7. BCC6760 7-Hydroxy-PIPAT maleate 200722-46-9 7-Hydroxy-PIPAT maleate chemical structure
  8. BCN2181 Pramipexole dihydrochloride Pramipexole dihydrochloride is a partial/full D2S, D2L, D3, D4 receptor agonist with a Ki of 3.9, 2.2, 0.5 and 5.1 nM for D2S, D2L, D3, D4 receptor, respectively. Pramipexole dihydrochloride chemical structure
  9. BCC7193 Eticlopride hydrochloride 97612-24-3 Eticlopride hydrochloride chemical structure
  10. BCC7025 Nafadotride 149649-22-9 Nafadotride chemical structure
  11. BCC7435 NGB 2904 189061-11-8 NGB 2904 chemical structure

Items 201 to 210 of 509 total